Skip to content

Clinical study of the effect of Auricular Acupressure on uterine involution after cesarean delivery

Clinical study of the effect of Auricular Acupressure on uterine involution after cesarean delivery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015569
Enrollment
Unknown
Registered
2018-03-19
Start date
2018-04-16
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subinvolution of uterus

Interventions

false auricular acupressure group:false auricular acupressure

Sponsors

First Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. nulliparous patients; 2. between 20 and 40 years old (including 20 and 40 years old), the height is greater than 145cm, and the gestational age (37 weeks and <42 weeks), single pregnancy, and cesarean delivery; 3. cesarean section by transverse incision in the lower segment, and intraoperative bleeding less than 400ml; 4. neonatal weight is greater than 2500g and < 4000g, no neonatal asphyxia, no need to be admitted into intensive care unit, and after birth,room of mother and infant; 5. no previous impact on the basic diseases of breast-feeding and the selection of breast-feeding after delivery; 6. primipara or family member signed the informed consent and agreed to accept the test.

Exclusion criteria

Exclusion criteria: 1. ever have reproductive tract deformity, no uterus disease (such as hysteromyoma, adenomyosis, etc.); 2. have pregnancy complications, pregnancy with internal or surgical diseases , etc,during pregnancy; 3. obstetric complications during delivery (such as postpartum hemorrhage, amniotic fluid embolism,etc.); 4. amniotic fluid volume abnormality, such as polyhydramnios or hypamnios; 5. moderate or severe anemia; 6. have been accepted drug treatment of inhibiting uterine contraction 48 hours before cesarean section; 7. coagulation function was significantly abnormal; 8. with some reasons can not to breastfeed.

Design outcomes

Primary

MeasureTime frame
Size of the uterus;Height of fundus of uterus;The speed of uterine involution;

Secondary

MeasureTime frame
Bleeding;Hemoglobin;Erythrocyte counts;Duration of lochia rubra;

Countries

China

Contacts

Public ContactShuxin Wang

First Affiliated Hospital of Guangzhou University of Chinese Medicine

widiot@126.com+86 13660285076

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 23, 2026